Annoni Marco
Interdepartmental Center for Research Ethics and Integrity (CID Ethics), National Research Council, Rome, Italy
J Med Ethics. 2025 Jul 7;51(7):450-455. doi: 10.1136/jme-2024-110343.
This article challenges two dominant assumptions in the current ethical debate over the use of algorithmic Personalised Patient Preference Predictors (P4) in substitute judgement for incapacitated patients. First, I question the belief that the autonomy of a patient who no longer has decision-making capacity can be meaningfully respected through a P4-empowered substitute judgement. Second, I critique the assumption that respect for autonomy can be reduced to merely satisfying a patient's individual treatment preferences. Both assumptions, I argue, are problematic: respect for autonomy cannot be equated with simply delivering the 'right' treatments, and expanding the normative scope of agency beyond first-person decisions creates issues for standard clinical decision-making. I suggest, instead, that the development of these algorithmic tools can be justified by achieving other moral goods, such as honouring a patient's unique identity or reducing surrogate decision-makers' burdens. This conclusion, I argue, should reshape the ethical debate around not just the future development and use of P4-like systems, but also on how substitute judgement is currently understood and justified in clinical medicine.
本文对当前关于使用算法个性化患者偏好预测器(P4)为无行为能力患者进行替代判断的伦理辩论中的两个主流假设提出了挑战。首先,我质疑这样一种观点,即通过P4赋能的替代判断能够有意义地尊重不再具备决策能力的患者的自主性。其次,我批判了那种认为尊重自主性可以简化为仅仅满足患者个人治疗偏好的假设。我认为,这两个假设都存在问题:尊重自主性不能等同于简单地提供“正确”的治疗,并且将代理的规范范围扩展到第一人称决策之外会给标准临床决策带来问题。相反,我认为这些算法工具的开发可以通过实现其他道德目标来证明其合理性,比如尊重患者的独特身份或减轻替代决策者的负担。我认为,这一结论不仅应该重塑围绕类似P4系统的未来发展和使用的伦理辩论,还应该重塑目前在临床医学中对替代判断的理解和正当性的辩论。